Disaster Lit® Database Daily Updates

Disaster Lit® Database Daily Updates

Statement on the Meeting of the International Health Regulations (2005) Emergency Committee for Ebola Virus Disease in the Democratic Republic of the Congo on 18 October 2019

10/18/2019 12:00 AM EDT

Source: World Health Organization (WHO). Published: 10/18/2019. This report summarizes a meeting held on October 18, 2019, to review the current Ebola virus disease outbreak in the Democratic Republic of the Congo. Uganda emphasized the efforts to vaccinate health care workers and strengthen community village health teams in the at-risk districts to enhance community surveillance. Tanzania provided an update on its preparedness efforts, which have continued since September 2018, through the Ebola Contingency plan, under the leadership of the National Task Force. The World Health Organization Secretariat provided details on the latest risk assessment. (Text)

Infection Control in Healthcare Personnel: Infrastructure and Routine Practices for Occupational Infection Prevention and Control Services

10/01/2019 12:00 AM EDT

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 10/2019. This 70-page document is an update of four sections of Part I of the guideline for infection control in health care personnel, 1998. The recommendations in this document update the 1998 recommendations with a broader range of elements necessary for providing occupational infection prevention and control services to healthcare personnel; and applicability to the wider range of healthcare settings where patient care is now delivered, including hospital-based, long-term care, and outpatient settings such as ambulatory and home healthcare. (PDF)

WHO (World Health Organization) Emergency Use Assessment and Listing for Ebola Virus Disease IVDs (In Vitro Diagnostics): Public Report; Product: OraQuick® Ebola Rapid Antigen Test Kit

10/01/2019 12:00 AM EDT

Source: World Health Organization (WHO). Published: 10/2019. This six-page document describes the emergency use assessment and listing for Ebola virus disease in vitro diagnostics for the OraQuick® Ebola Rapid Antigen Test Kit. It consists of a desktop review of selected manufacturing and quality management system documentation; the review of any existing documentary evidence of safety and performance; and a limited performance evaluation of relevant performance characteristics of the product. (PDF)

Epi CASE (Epidemiologic Case Assessment of Symptoms and Exposure) Toolkit

09/19/2019 12:00 AM EDT

Source: Agency for Toxic Substances and Disease Registry (ATSDR). Published: 9/19/2019. This toolkit can guide public health professionals when a disaster or other emergency strikes, and state, local, tribal and territorial health authorities have immediate information needs. They may need to know how many people were exposed to hazardous agents (chemical, radiological, nuclear, biological, or other hazardous agent), and if they are experiencing symptoms or have any immediate needs. The toolkit can guide public health professionals toward the next practical steps, which may include developing a health registry. (Text)

Home Health Care in the Dark: Why Climate, Wildfires and Other Risks Call for New Resilient Energy Storage Solutions to Protect Medically Vulnerable Households From Power Outages

06/04/2019 12:00 AM EDT

Source: Clean Energy Group. Published: 6/4/2019. This 34-page report examines the risks associated with power outages for individuals reliant on electricity for in-home medical and mobility equipment. It discusses how natural disasters and severe weather are resulting in more frequent and longer duration power outages, and current energy security technologies and policies will need to adjust to meet the needs of the home health care community. The report includes concrete recommendations for policymakers and public health professionals. (PDF)

WHO (World Health Organization) Emergency Use Assessment and Listing for Ebola Virus IVDs (In Vitro Diagnostics): Public Report; Product: Xpert Ebola Assay (2019)

06/01/2019 12:00 AM EDT

Source: World Health Organization (WHO). Published: 6/2019. This five-page document describes the 2019 updated emergency use assessment and listing for Ebola virus in vitro diagnostics for Xpert Ebola Assay, which is a rapid, automated test for qualitative detection of the Zaire strain of the Ebola virus. It is performed on the Cepheid GeneXpert Instrument Systems, and is a real-time reverse transcription polymerase chain reaction (RT-PCR) test intended for the qualitative detection of RNA from the Ebola Zaire virus. (PDF)

WHO (World Health Organization) Emergency Use Assessment and Listing for EVD (Ebola Virus Disease) IVDs (In Vitro Diagnostics): Public Report; Product: STANDARD™ Q Ebola Zaire Ag (2019)

02/01/2019 12:00 AM EST

Source: World Health Organization (WHO). Published: 2/2019. This four-page document describes the 2019 updated emergency use assessment and listing for Ebola virus disease in vitro diagnostics for STANDARD™ Q Line Ebola Zaire Ag. It is a chromatographic immunoassay for the presumptive qualitative detection of Ebola Zaire virus disease in whole blood, plasma, or serum from individuals with signs and symptoms of Ebola virus infection in affected areas in conjunction with relevant epidemiological risk factors. (PDF)